Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $8.0 million.

  • Alignment Healthcare's Depreciation & Amortization (CF) rose 389.02% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.5 million, marking a year-over-year increase of 1279.34%. This contributed to the annual value of $27.1 million for FY2024, which is 2489.39% up from last year.
  • Alignment Healthcare's Depreciation & Amortization (CF) amounted to $8.0 million in Q3 2025, which was up 389.02% from $7.0 million recorded in Q2 2025.
  • Alignment Healthcare's Depreciation & Amortization (CF)'s 5-year high stood at $8.0 million during Q3 2025, with a 5-year trough of $3.8 million in Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $5.3 million (2023), whereas its average is $5.5 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first decreased by 19.24% in 2021, then soared by 3821.26% in 2024.
  • Alignment Healthcare's Depreciation & Amortization (CF) (Quarter) stood at $4.1 million in 2021, then increased by 14.51% to $4.8 million in 2022, then rose by 23.36% to $5.9 million in 2023, then rose by 16.16% to $6.8 million in 2024, then grew by 17.29% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q3 2025, $7.0 million for Q2 2025, and $7.6 million during Q1 2025.